Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

Pfizer Inc. (NYSE:PFE) released topline results from its Phase 3 CREST trial evaluating sasanlimab, an investigational ...

Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases, today announced its launch with $120 million in funding. The ...

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

Mona Jain take charge as the new Chief Growth Officer at BrandPulse Global and will be based out of the company’s Noida ...

In fact, from Merck's $1.3 billion deal to GSK's $850 million investment, the "gold content" of Chinese companies' self-developed TCE bispecific antibodies has already been well proven. The new moves ...

RNA is a long, polymeric molecule, composed of four different building blocks called nucleotides. In the last decade mRNA has progressed into a promising new class of medicine, with the potential to ...

The company is hoping ... (elranatamab). On GSK's third-quarter results call, chief commercial officer Luke Miels said there is an "increasing respect for the profile of the product," as well ...

ShareThe recent wave of delistings from the Nigerian Exchange (NGX) by notable companies such as Flour Mills of Nigeria (FMN) and GlaxoSmithKline (GSK) has sparked conversations among investors, ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.